Voyageur Pharmaceuticals to settle $192,300 debt with common shares
Voyageur Pharmaceuticals (TSXV:VM) has proposed a settlement for $192,300 in outstanding debts by issuing common shares at a deemed price of $0.155 per share. The company will issue 337,419 shares to settle $52,300 owed to an officer for consulting fees and another 903,226 shares to address the remaining $140,000 in obligations to other creditors. The deemed price of $0.155 per share corresponds to Voyageur’s closing stock price on September 24, 2026, as listed on the TSX Venture Exchange. The total number of shares issued under this arrangement will be approximately 1.24 million. This move is intended to resolve existing liabilities without requiring cash outflows. The settlement reflects a common strategy among small-cap companies with limited liquidity to manage debt obligations through equity issuance.
Topics: debt restructuring equity financing TSX Venture Exchange